Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 27,600
Avg Vol 13,788
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 56%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer,...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 41 61 688 88 80
Fax: 41 61 691 00 14
Address:
Grenzacherstrasse 124, Basel, Switzerland
GoforProMIS
GoforProMIS Jul. 14 at 10:25 AM
$PMN with best in class results at the Alzheimer’s Association International Conference (AAIC) as the world’s largest and most important professional conference dedicated to Alzheimer’s and dementia research. Key figures: Around 12,000 participants from across the globe attended AAIC 2025. Of these, over 8,000 attended in person, while more than 3,000 joined online. Participants came from 139 countries. Participants include: Neurologists Alzheimer’s researchers Representatives from universities Pharmaceutical companies $LLY , $BIIB , $RHHVF , $ESALY , etc. Investors and biotech analysts FDA and regulatory representatives Clinical trial investigators. Get ready for amazing day, week and months to come 🚀 https://www.promisneurosciences.com/investors/news-events/press-releases/detail/269/promis-neurosciences-reports-first-human-evidence-of
0 · Reply
clan
clan Jun. 1 at 1:43 PM
$MNKD For the good of all Mannkind, on Wednesday, the CEO speaks at the Jefferies Global Health Care conference. Afrezza c/b Blockbuster Nintedanib DPI t/b Blockbuster Tyvaso DPI is Blockbuster Ralinepag DPI t/b Blockbuster Furoscix AutoInjector t/b Blockbuster $RHHVF $RHHBY $IBB take notice.
0 · Reply
trenddetector
trenddetector Apr. 2 at 6:18 PM
$RHHVF Share this site with anyone that has cancer and is searching for options. A great resource for those confused about approved treatments and trials that are enrolling. https://nimble-frangollo-81ff5e.netlify.app/#
0 · Reply
Latest News on RHHVF
No data available.
GoforProMIS
GoforProMIS Jul. 14 at 10:25 AM
$PMN with best in class results at the Alzheimer’s Association International Conference (AAIC) as the world’s largest and most important professional conference dedicated to Alzheimer’s and dementia research. Key figures: Around 12,000 participants from across the globe attended AAIC 2025. Of these, over 8,000 attended in person, while more than 3,000 joined online. Participants came from 139 countries. Participants include: Neurologists Alzheimer’s researchers Representatives from universities Pharmaceutical companies $LLY , $BIIB , $RHHVF , $ESALY , etc. Investors and biotech analysts FDA and regulatory representatives Clinical trial investigators. Get ready for amazing day, week and months to come 🚀 https://www.promisneurosciences.com/investors/news-events/press-releases/detail/269/promis-neurosciences-reports-first-human-evidence-of
0 · Reply
clan
clan Jun. 1 at 1:43 PM
$MNKD For the good of all Mannkind, on Wednesday, the CEO speaks at the Jefferies Global Health Care conference. Afrezza c/b Blockbuster Nintedanib DPI t/b Blockbuster Tyvaso DPI is Blockbuster Ralinepag DPI t/b Blockbuster Furoscix AutoInjector t/b Blockbuster $RHHVF $RHHBY $IBB take notice.
0 · Reply
trenddetector
trenddetector Apr. 2 at 6:18 PM
$RHHVF Share this site with anyone that has cancer and is searching for options. A great resource for those confused about approved treatments and trials that are enrolling. https://nimble-frangollo-81ff5e.netlify.app/#
0 · Reply